Chiome Bioscience Inc
TSE:4583
Chiome Bioscience Inc
Operating Expenses
Chiome Bioscience Inc
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
Chiome Bioscience Inc
TSE:4583
|
Operating Expenses
-¥1.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-7%
|
CMIC Holdings Co Ltd
TSE:2309
|
Operating Expenses
-¥15.3B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
S
|
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
|
Operating Expenses
-¥10.1B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-5%
|
Medinet Co Ltd
TSE:2370
|
Operating Expenses
-¥1.5B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
1%
|
CAGR 10-Years
3%
|
|
CellSource Co Ltd
TSE:4880
|
Operating Expenses
-¥2B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
Linical Co Ltd
TSE:2183
|
Operating Expenses
-¥3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-15%
|
See Also
What is Chiome Bioscience Inc's Operating Expenses?
Operating Expenses
-1.6B
JPY
Based on the financial report for Dec 31, 2023, Chiome Bioscience Inc's Operating Expenses amounts to -1.6B JPY.
What is Chiome Bioscience Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-7%
Over the last year, the Operating Expenses growth was 0%. The average annual Operating Expenses growth rates for Chiome Bioscience Inc have been -2% over the past three years , 1% over the past five years , and -7% over the past ten years .